Related Experiment Video
Updated: Mar 8, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Cancer and Thrombosis: The Platelet Perspective
Claire K S Meikle1, Clare A Kelly1, Priyanka Garg1
1Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences Toledo, OH, USA.
Platelets are crucial in hemostasis and immunity, significantly impacting cancer progression, metastasis, and thrombosis. Understanding platelet-tumor cell interactions may reveal biomarkers for cancer and thrombosis risk.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Platelets are vital for hemostasis and immune responses.
- Platelets play a significant role in cancer progression, metastasis, and thrombosis.
- Interactions between platelets, immune cells, and tumor cells are complex and multifaceted.
Purpose of the Study:
- To elucidate the multifaceted roles of platelets in cancer progression and metastasis.
- To investigate the mechanisms by which platelets facilitate tumor growth, invasion, and immune evasion.
- To explore the contribution of tumor cell-activated platelets to cancer-related thrombosis.
Main Methods:
- Literature review and synthesis of current research on platelet function in cancer.
- Analysis of platelet interactions with tumor cells and immune cells.
- Examination of the molecular mechanisms underlying platelet-mediated cancer progression and thrombosis.
Main Results:
- Platelets promote cancer progression by aiding tumor cell aggregation, growth, epithelial-mesenchymal transition, and invasion.
- Platelets shield circulating tumor cells from immune surveillance and facilitate their arrest and establishment at distant sites.
- Tumor cell-activated platelets contribute to thrombosis by secreting procoagulant factors, leading to clot formation.
Conclusions:
- Platelets are key drivers of cancer progression, metastasis, and thrombosis.
- Platelet-tumor cell interactions offer potential therapeutic targets and diagnostic biomarkers.
- Further research into platelet biology in cancer is warranted to improve patient outcomes.
More Related Videos
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...